August 10, 2022 12:31 PM
Latest:
  • Coinbase Widens Net Loss In Q2 2022 At US$1.09 Billion, Bloats Asset Size Five Times By Assuming Liability Of Customers’ Assets
  • US Inflation FINALLY Stagnates in July, But Real Wages Are Still Plummeting
  • Ned Goodman, Canadian Mining Legend, Passes Away
  • Telus Looks To Be The First Telecom To Charge Credit Card Processing Fees
  • Americans’ Confidence in the Housing Market Plummets to 10-Year Low Amid Rising Mortgage Rates
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Healthcare
      • Bright Minds Biosciences
      • VentriPoint Diagnostics
    • Resources
      • Carbon Streaming Corp
      • Denarius Silver
      • Hemlo Explorers
      • Nickel 28 Capital
      • Prime Meridian Resources
      • Riverside Resources
      • Vortex Metals
    • Technology
      • MustGrow Biologics
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Pharmather

Briefing Psychedelics 

PharmaTher Secures Japanese Patent For Ketabet

November 30, 2021 9:52 AMNovember 30, 2021 9:16 AM ER Velasco 0 Comments Pharmather

PharmaTher Holdings (CSE: PHRM) announced today that it has been granted a Japanese patent for its ketamine combination formulation, Ketabet. The

Share
Tweet
Share
Read more
Briefing Psychedelics 

PharmaTher To Raise $10.0 Million Via Institutional Investor Financing

September 24, 2021 8:28 AMSeptember 24, 2021 8:28 AM Jay Lutz 0 Comments Pharmather

PharmaTher Holdings (CSE: PHRM) this morning indicated that the company has secured a financing with institutional investors. The firm will

Share
Tweet
Share
Read more
Briefing Psychedelics 

PharmaTher: Maxim Initiates Coverage With US$1.50 Price Target

June 30, 2021 2:38 PMJune 30, 2021 10:17 AM Justin Young 0 Comments Analyst Estimate, Pharmather

PharmaTher Holdings (CSE: PHRM) had its first initiation report that came out on June 28th. Maxim Group initiated coverage on

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Applies For Pre-IND Meeting With US FDA For Ketabet

June 15, 2021 8:14 AMJune 15, 2021 8:14 AM Jay Lutz 0 Comments Pharmather

PharmaTher Holdings (CSE: PHRM) this morning announced that it continues to push forward with the development of Ketabet. The company

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Partners With TSRL For Microneedle Patch Development

June 1, 2021 8:21 AMJune 1, 2021 8:21 AM Jay Lutz 0 Comments Pharmather

PharmaTher Holdings (CSE: PHRM) has partnered with that of TSRL under a co-development agreement. The arrangement will see the two

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Files With FDA For Orphan Drug Designation In Use Of Ketamine For ALS

May 25, 2021 9:00 AMMay 25, 2021 9:00 AM Jay Lutz 0 Comments Ketamine, Pharmather

PharmaTher Holdings (CSE: PHRM) this morning announced that it has filed with the US FDA for orphan drug designation as

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Receives FDA Approval For Ketamine Trial For Parkinson’s

May 17, 2021 9:15 AMMay 17, 2021 9:15 AM Jay Lutz 0 Comments Ketamine, Pharmather

PharmaTher Holdings (CSE: PHRM) has seen the US FDA approve the firms application for an investigational new drug. The approval

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Files Patent For Use Of Ketamine In Type 2 Diabetes, Obesity

April 27, 2021 7:54 AMApril 27, 2021 7:54 AM Jay Lutz 0 Comments Pharmather

PharmaTher Holdings (CSE: PHRM) has expanded its patent portfolio. The company this morning announced the filing of a provisional patent

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Submits For Phase 2 Clinical Trial With FDA

April 20, 2021 7:38 AMApril 20, 2021 7:38 AM Jay Lutz 0 Comments Pharmather

PharmaTher Holdings (CSE: PHRM) is looked to complete a phase two clinical trial. The company this morning announced the submittal

Share
Tweet
Share
Read more
Briefing News Psychedelics 

PharmaTher Sponsors Research For Novel Delivery Of Ketamine

March 24, 2021 7:19 AMMarch 24, 2021 7:19 AM Jay Lutz 0 Comments Pharmather

PharmaTher Inc (CSE: PHRM) this morning announced that it has entered into a sponsored research agreement. The agreement, which was

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Coinbase Widens Net Loss In Q2 2022 At US$1.09 Billion, Bloats Asset Size Five Times By Assuming Liability Of Customers’ Assets
Blockchain Briefing 

Coinbase Widens Net Loss In Q2 2022 At US$1.09 Billion, Bloats Asset Size Five Times By Assuming Liability Of Customers’ Assets

August 10, 2022 12:21 PM ER Velasco 0

Coinbase Global (Nasdaq: COIN) reported its Q2 2022 financials, toplined by a quarterly net revenue of US$802.6 million. This is a

US Inflation FINALLY Stagnates in July, But Real Wages Are Still Plummeting
Briefing Macro 

US Inflation FINALLY Stagnates in July, But Real Wages Are Still Plummeting

August 10, 2022 11:33 AM Hermina Paull 0
Ned Goodman, Canadian Mining Legend, Passes Away
Briefing Resources 

Ned Goodman, Canadian Mining Legend, Passes Away

August 10, 2022 10:57 AM JP Alegre 0
Telus Looks To Be The First Telecom To Charge Credit Card Processing Fees
Briefing Technology 

Telus Looks To Be The First Telecom To Charge Credit Card Processing Fees

August 10, 2022 10:05 AM Jay Lutz 0
Americans’ Confidence in the Housing Market Plummets to 10-Year Low Amid Rising Mortgage Rates
Briefing Macro 

Americans’ Confidence in the Housing Market Plummets to 10-Year Low Amid Rising Mortgage Rates

August 10, 2022 9:39 AM Hermina Paull 0
Pure Gold Sees Mineral Resources, Grades Decline In Latest Estimate Update
Briefing Resources 

Pure Gold Sees Mineral Resources, Grades Decline In Latest Estimate Update

August 10, 2022 8:47 AM Jay Lutz 0
Trulieve Sees Flat Q2 Results, Lowers Guidance For Full Fiscal Year
Briefing Cannabis 

Trulieve Sees Flat Q2 Results, Lowers Guidance For Full Fiscal Year

August 10, 2022 8:21 AM Jay Lutz 0

Spotlight Series

Are We Headed Towards A Bull Market? – With Michael Williams Of Vortex Metals
Briefing Resources Video Series 

Are We Headed Towards A Bull Market? – With Michael Williams Of Vortex Metals

August 9, 2022 1:30 PM Jay Lutz 0

Joining SmallCapSteve today is Michael Williams, Executive Chairman of Vortex Metals (TSXV: VMS). Michael sits down with us to share

News

First Lithium: The Newest Issuer On The CSE
Briefing News Resources 

First Lithium: The Newest Issuer On The CSE

August 9, 2022 3:55 PM Jay Lutz 0

First Lithium Minerals (CSE: FLM) commenced trading this morning on the Canadian Securities Exchange. The firm is the latest lithium

Max Resource Identifies Two IP Drill Targets At Cesar Property
Briefing News Resources 

Max Resource Identifies Two IP Drill Targets At Cesar Property

August 9, 2022 8:28 AM Jay Lutz 0
NG Energy Begins Production At Maria Conchita Gas Field
Briefing Energy News 

NG Energy Begins Production At Maria Conchita Gas Field

August 8, 2022 8:39 AM Jay Lutz 0
Emerita Resources Intersects 7.0 Metres Of 0.8% Copper At Romanera
Briefing News Resources 

Emerita Resources Intersects 7.0 Metres Of 0.8% Copper At Romanera

August 5, 2022 9:21 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Psychedelics
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2022 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.